Minimally Invasiveโ Techniques Revolutionize Aortic Aneurysm Treatment, KRH Clinics Leadโ Regional Care
Gehrden/Hanover, Germany โ – A recent specialist event hosted by KRH Klinikum Robert Koch Gehrden and KRH klinikum Siloah highlighted the dramatic advancements in treating aortic aneurysms, shifting from major open surgery to less invasive, custom-fitted stent procedures. The event underscored the โฃgrowing prominence of endovascular repair as the standardโค of care, offering patients faster recovery times and increased precision.
Historically, aortic aneurysms – bulges in the aorta โข- required extensive and stressfulโ open-heartโ operations. Today, however, the landscape of treatment has โbeen transformed by the advancement ofโฃ stent prostheses tailored to individual patient needs.โ These prostheses are deployed via small incisions in the groin, stabilizing the aorta without the โneedโค for large surgical openings. In many โcases,these proceduresโ canโ even beโข performed without generalโค anesthesia.
The โขKRH Gehrdenโ Clinic and KRH siloah Clinic have established themselves as regional leaders in providing this advanced care, adhering to theโข standards set by the jointโ federal committee for aortic aneurysm patients. This success isโ built on a foundation of close interdisciplinary collaboration.
“Vascular โคsurgeons, angiologists and radiologists have to work hand in hand,” explained Dr. โGรถtz Voshage, Medical Director of โthe KRH Institute for Radiology and Chiefโค physicianโ of the Radiology Departments at KRH Klinikum Robert Koch Gehrdenโฃ and Neustadt amโ Rรผbenberge.”This is the only way we canโ offer our patients theโ best possible therapy.”
Theโ specialistโค event, focused on “Techniques for endovascular โand surgical treatment of aortic aneurysms,” provided a platform for knowledge sharing and professional exchange. Experienced specialists engaged directlyโ with both referring colleagues and young doctors, fostering a collaborative learning habitat.
The event was madeโ possible thru the support of sponsors including Siemens Healthineers,Medtronic,Lombard Endovastec,Gore,Artivion and โterumo Aortic,whoโค providedโฃ factsโ and direct dialog opportunities for attendees.
The shift towards endovascular treatment represents a significant leap forward โขin cardiovascular โขcare, offering patients a less invasive path to recovery โคand improved quality of life. The KRH Klinikum Robert Koch Gehrden and KRH Klinikum siloah are atโ theโ forefront of deliveringโ this cutting-edgeโ treatment within the โHanover region.
Key personnel involved in the interdisciplinary vascular medicine team include: โขProf. Dr. Jochen Wedemeyer,โ Dr. Gรถtz โVoshage, Prof. Dr. Hans-Gerd Fieguth, Dr. Nikolaj Mokov, Ole Brenning, Dr. manuel Lehm, Gerd Thomas Oehlert, and Dr. Hans Peter Lorenzen. Dr. Michael Maringka was โabsent from the pictured team.